N López-Vilanova1,2, J Pavía3,4,5, M A Duch6, A Catafau5,7, D Ros3,5,8, S Bullich9. 1. Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Barcelona, Spain. nl.vilanova@gmail.com. 2. Institut de Tècniques Energètiques (INTE), Universitat Politècnica de Catalunya (UPC), Barcelona, Spain. nl.vilanova@gmail.com. 3. Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Barcelona, Spain. 4. Nuclear Medicine Department, Hospital Clínic i Provincial de Barcelona, Barcelona, Spain. 5. Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. 6. Institut de Tècniques Energètiques (INTE), Universitat Politècnica de Catalunya (UPC), Barcelona, Spain. 7. Barcelona Imaging Group (BIG), Barcelona, Spain. 8. Unitat de Biofísica i Bioenginyeria, Universitat de Barcelona, Barcelona, Spain. 9. Molecular Imaging Centre (CRC-CIM), Barcelona Biomedical Research Park, Barcelona, Spain.
Abstract
PURPOSE: Human dosimetry studies play a central role in radioligand development for positron emission tomography (PET). Drawing regions of interest (ROIs) on the PET images is used to measure the dose in each organ. In the study aspects related to ROI delineation methods were evaluated for two radioligands of different biodistribution (intestinal vs urinary). PROCEDURES: PET images were simulated from a human voxel-based phantom. Several ROI delineation methods were tested: antero-posterior projections (AP), 3D sub-samples of the organs (S), and a 3D volume covering the whole-organ (W). Inter- and intra-operator variability ROI drawing was evaluated by using human data. RESULTS: The effective dose estimates using S and W methods were comparable to the true values. AP methods overestimated (49 %) the dose for the radioligand with intestinal biodistribution. Moreover, the AP method showed the highest inter-operator variability: 11 ± 1 %. CONCLUSIONS: The sub-sampled organ method showed the best balance between quantitative accuracy and inter- and intra-operator variability.
PURPOSE:Human dosimetry studies play a central role in radioligand development for positron emission tomography (PET). Drawing regions of interest (ROIs) on the PET images is used to measure the dose in each organ. In the study aspects related to ROI delineation methods were evaluated for two radioligands of different biodistribution (intestinal vs urinary). PROCEDURES: PET images were simulated from a human voxel-based phantom. Several ROI delineation methods were tested: antero-posterior projections (AP), 3D sub-samples of the organs (S), and a 3D volume covering the whole-organ (W). Inter- and intra-operator variability ROI drawing was evaluated by using human data. RESULTS: The effective dose estimates using S and W methods were comparable to the true values. AP methods overestimated (49 %) the dose for the radioligand with intestinal biodistribution. Moreover, the AP method showed the highest inter-operator variability: 11 ± 1 %. CONCLUSIONS: The sub-sampled organ method showed the best balance between quantitative accuracy and inter- and intra-operator variability.
Authors: Vanessa L Cropley; Masahiro Fujita; John L Musachio; Jinsoo Hong; Subroto Ghose; Janet Sangare; Pradeep J Nathan; Victor W Pike; Robert B Innis Journal: J Nucl Med Date: 2006-01 Impact factor: 10.057
Authors: Noora M Scheinin; Tuula K Tolvanen; Ian A Wilson; Eveliina M Arponen; Kjell A Någren; Juha O Rinne Journal: J Nucl Med Date: 2007-01 Impact factor: 10.057
Authors: Marie-José Bélanger; Norman R Simpson; Theodore Wang; Ronald L Van Heertum; J John Mann; Ramin V Parsey Journal: Nucl Med Biol Date: 2004-11 Impact factor: 2.408
Authors: Koen Van Laere; Michel Koole; Sandra M Sanabria Bohorquez; Karolien Goffin; Ilonka Guenther; Marie J Belanger; Josee Cote; Paul Rothenberg; Inge De Lepeleire; Igor D Grachev; Richard J Hargreaves; Guy Bormans; H Donald Burns Journal: J Nucl Med Date: 2008-02-20 Impact factor: 10.057
Authors: David R Sprague; Masahiro Fujita; Yong Hoon Ryu; Jeih-San Liow; Victor W Pike; Robert B Innis Journal: Nucl Med Biol Date: 2008-05 Impact factor: 2.408